Laura Williams

4.1k total citations · 1 hit paper
58 papers, 2.6k citations indexed

About

Laura Williams is a scholar working on Endocrinology, Diabetes and Metabolism, Nephrology and Psychiatry and Mental health. According to data from OpenAlex, Laura Williams has authored 58 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Endocrinology, Diabetes and Metabolism, 12 papers in Nephrology and 12 papers in Psychiatry and Mental health. Recurrent topics in Laura Williams's work include Parathyroid Disorders and Treatments (11 papers), Sexual function and dysfunction studies (7 papers) and Lipoproteins and Cardiovascular Health (7 papers). Laura Williams is often cited by papers focused on Parathyroid Disorders and Treatments (11 papers), Sexual function and dysfunction studies (7 papers) and Lipoproteins and Cardiovascular Health (7 papers). Laura Williams collaborates with scholars based in United States, United Kingdom and Canada. Laura Williams's co-authors include Jianhua Tian, Adeera Levin, Mark E. Molitch, George L. Bakris, D.L. Andress, Maartje Smulders, Ping Qiu, Joel Z. Melnick, Daniel Batlle and Muralidhar Acharya and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of the American College of Cardiology and Cancer Research.

In The Last Decade

Laura Williams

53 papers receiving 2.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: Results of the study to evaluate early kidney disease

2006 1.1k citations Laura Williams et al. Kidney International profile →

Peers

Countries citing papers authored by Laura Williams

Since Specialization

Citations

This map shows the geographic impact of Laura Williams's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura Williams with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura Williams more than expected).

Fields of papers citing papers by Laura Williams

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laura Williams. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura Williams. The network helps show where Laura Williams may publish in the future.

Co-authorship network of co-authors of Laura Williams

This figure shows the co-authorship network connecting the top 25 collaborators of Laura Williams. A scholar is included among the top collaborators of Laura Williams based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laura Williams. Laura Williams is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Intestinal Permeability, Irritable Bowel Syndrome with Constipation, and the Role of Sodium-Hydrogen Exchanger Isoform 3 (NHE3) 2024 ·Clinical and Experimental Gastroenterology ·Brian E. Lacy, David P. Rosenbaum, (unknown), Kenji Kozuka, Laura Williams, David C. Kunkel	2
2	Building‐Block Size Mediates Microporous Annealed Particle Hydrogel Tube Microenvironment Following Spinal Cord Injury 2023 ·Advanced Healthcare Materials ·(unknown), Robert Kent, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Laura Williams, Aileen J. Anderson, B. Cummings, Brendon M. Baker, Lonnie D. Shea	8
3	Family Needs Assessment of Patients with Cerebral Palsy Attending Two Hospitals in Accra, Ghana 2023 ·Children ·(unknown), (unknown), (unknown), (unknown), (unknown), Laura Williams, Benedict Calys‐Tagoe, (unknown), Edem M. A. Tette	5
4	Assessing the Burden of Illness Associated with Acquired Generalized Hypoactive Sexual Desire Disorder 2022 ·Journal of Women s Health ·James A. Simon, (unknown), (unknown), Nandini Hadker, (unknown), (unknown), Laura Williams, Julie Krop	9
5	The Patient Experience of Premenopausal Women Treated with Bremelanotide for Hypoactive Sexual Desire Disorder: RECONNECT Exit Study Results 2021 ·Journal of Women s Health ·Patricia Koochaki, Dennis A. Revicki, Hilary Wilson, Robin Pokrzywinski, Robert Jordan, Johna Lucas, Laura Williams, (unknown), Julie Krop	10
6	Faculty-Created Competition to Enhance Scholarly Writing for Students in a Baccalaureate Nursing Program 2020 ·Nurse Educator ·Laura Williams, (unknown)	0
7	Bremelanotide for the Treatment of Hypoactive Sexual Desire Disorder 2019 ·Obstetrics and Gynecology ·Sheryl A. Kingsberg, Anita H. Clayton, David Portman, Laura Williams, Julie Krop, Robert Jordan, Johna Lucas, James A. Simon	89
8	Long-Term Safety and Efficacy of Bremelanotide for Hypoactive Sexual Desire Disorder 2019 ·Obstetrics and Gynecology ·James A. Simon, Sheryl A. Kingsberg, David Portman, Laura Williams, Julie Krop, Robert Jordan, Johna Lucas, Anita H. Clayton	35
9	Connecting Families to Their Health Record and Care Team: The Use, Utility, and Impact of a Client/Family Health Portal at a Children’s Rehabilitation Hospital 2017 ·Journal of Medical Internet Research ·Gillian King, Joanne Maxwell, (unknown), Simon Hagens, Madhu Pinto, Laura Williams, Keith Adamson	35
10	RESULTS FROM THE FENOFIBRIC ACID ON CAROTID INTIMA-MEDIA THICKNESS IN SUBJECTS WITH TYPE IIB DYSLIPIDEMIA WITH RESIDUAL RISK IN ADDITION TO ATORVASTATIN THERAPY (FIRST) TRIAL 2013 ·Journal of the American College of Cardiology ·Michael H. Davidson, Robert S. Rosenson, Kevin C. Maki, Stephen J. Nicholls, Christie M. Ballantyne, Theodore Mazzone, Laura Williams, Maureen T. Kelly, Heidi S. Camp, (unknown), James C. Stolzenbach	1
11	Exposure—Clinical Response Analysis of Paricalcitol in Patients With Chronic Kidney Disease (Stage 5) on Hemodialysis or Peritoneal Dialysis 2011 ·The Journal of Clinical Pharmacology ·Peter Noertersheuser, Rajendra Pradhan, Cheri E. Klein, Laura Williams, Rameshraja Palaparthy, Τushar Garimella, (unknown), Walid M. Awni	0
12	Efficacy and Safety of Rosuvastatin 5 mg in Combination with Fenofibric Acid 135 mg in Patients with Mixed Dyslipidemia – A Phase 3 Study 2010 ·Cardiovascular Drugs and Therapy ·Eli M. Roth, Robert S. Rosenson, Dawn M. Carlson, (unknown), Carolyn M. Setze, James W. Blasetto, Nardev S. Khurmi, James C. Stolzenbach, Laura Williams	20
13	Combination Rosuvastatin Plus Fenofibric Acid in a Cohort of Patients 65 Years or Older With Mixed Dyslipidemia: Subanalysis of Two Randomized, Controlled Studies 2010 ·Clinical Cardiology ·Carl J. Pepine, Terry A. Jacobson, Dawn M. Carlson, Maureen T. Kelly, Carolyn M. Setze, Alex Gold, James C. Stolzenbach, Laura Williams	7
14	Pharmacoepidemiology Safety Study of Fibrate and Statin Concomitant Therapy 2010 ·The American Journal of Cardiology ·Cheryl Enger, (unknown), Eileen E. Ming, Steve J. Niemcryk, Laura Williams, Andrew T. McAfee	54
15	Development of highly efficacious hydrophobic paclitaxel prodrugs delivered in nanoparticles for fixed-ratio drug combination applications 2008 ·Cancer Research ·Steven M. Ansell, Sharon A. Johnstone, Paul Tardi, (unknown), Sherwin Xie, Yu Shu, Troy O. Harasym, Natashia Harasym, Laura Williams, David Bermudes, Barry D. Liboiron, Walid Saad, Robert K. Prud’homme, Lawrence D. Mayer	3
16	Oral Paricalcitol for the Treatment of Secondary Hyperparathyroidism in Patients on Hemodialysis or Peritoneal Dialysis 2007 ·American Journal of Nephrology ·Edward A. Ross, Jin Tian, Hanna E. Abboud, (unknown), Joel Z. Melnick, Rajendra Pradhan, Laura Williams, L. Lee Hamm, Stuart M. Sprague	52
17	Antiproteinuric effect of oral paricalcitol in chronic kidney disease 2005 ·Kidney International ·Rajiv Agarwal, Muralidhar Acharya, Jin Tian, (unknown), Joel Z. Melnick, Ping Qiu, Laura Williams, Daniel Batlle	286
18	Intravenous calcitriol for treatment of hyperparathyroidism in children on hemodialysis 2005 ·Pediatric Nephrology ·Larry A. Greenbaum, Ryszard Grenda, Ping Qiu, Irene Restaino, (unknown), Ana Paredes, Nadine Benador, Joel Z. Melnick, Laura Williams, Isidro B. Salusky	16
19	The 2nd International Workshop on Clinical Pharmacology of HIV Therapy 2001 ·Expert Opinion on Pharmacotherapy ·Ann Hsu, Laura Williams, Thomas N. Kakuda	14
20	Catecholaminergic innervation of interscapular brown adipose tissue in the naked mole‐rat (Heterocephalus glaber) 1997 ·Journal of Anatomy ·Thomas J. Daly, Laura Williams, Rochelle Buffenstein	17

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact